Total Payments
$432,873
2024 Payments
$2,886
Companies
48
Transactions
1,306
Medicare Patients
2,473
Medicare Billing
$325,786
Payment Breakdown by Category
Other$339,385 (78.4%)
Travel$62,631 (14.5%)
Food & Beverage$27,355 (6.3%)
Consulting$3,252 (0.8%)
Education$249.16 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $339,385 | 192 | 78.4% |
| Travel and Lodging | $62,631 | 266 | 14.5% |
| Food and Beverage | $27,355 | 832 | 6.3% |
| Consulting Fee | $3,252 | 7 | 0.8% |
| Education | $249.16 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $174,491 | 324 | $0 (2024) |
| GlaxoSmithKline, LLC. | $86,213 | 211 | $0 (2024) |
| Mylan Specialty L.P. | $48,944 | 156 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $41,489 | 79 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $34,226 | 118 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $28,480 | 76 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,925 | 85 | $0 (2024) |
| GENZYME CORPORATION | $3,936 | 46 | $0 (2024) |
| Olympus Corporation of the Americas | $979.23 | 8 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $623.10 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,886 | 99 | GENZYME CORPORATION ($1,062) |
| 2023 | $6,021 | 119 | GENZYME CORPORATION ($2,112) |
| 2022 | $3,870 | 114 | Olympus Corporation of the Americas ($979.23) |
| 2021 | $5,245 | 95 | AstraZeneca Pharmaceuticals LP ($1,946) |
| 2020 | $33,324 | 106 | GlaxoSmithKline, LLC. ($18,192) |
| 2019 | $166,307 | 330 | GlaxoSmithKline, LLC. ($65,914) |
| 2018 | $84,413 | 205 | AstraZeneca Pharmaceuticals LP ($58,914) |
| 2017 | $130,806 | 238 | AstraZeneca Pharmaceuticals LP ($91,460) |
All Payment Transactions
1,306 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $112.14 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Neurology | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.16 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/15/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Pulmonology | ||||||
| 10/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/10/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 10/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 797 | 1,125 | $351,826 | $91,661 |
| 2022 | 16 | 706 | 1,081 | $336,496 | $85,532 |
| 2021 | 12 | 561 | 895 | $281,788 | $75,386 |
| 2020 | 9 | 409 | 692 | $186,792 | $73,208 |
Total Patients
2,473
Total Services
3,793
Medicare Billing
$325,786
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 281 | $103,170 | $25,409 | 24.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 68 | 189 | $61,929 | $17,677 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $30,989 | $7,141 | 23.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 45 | $23,652 | $6,135 | 25.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $27,736 | $5,619 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 38 | $19,418 | $4,983 | 25.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 25 | $16,815 | $4,194 | 24.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 64 | $12,774 | $3,980 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 49 | $8,780 | $3,438 | 39.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $10,950 | $3,085 | 28.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 50 | 52 | $8,372 | $2,210 | 26.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 49 | 51 | $7,938 | $2,149 | 27.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 49 | 51 | $6,367 | $1,548 | 24.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 45 | 45 | $4,479 | $1,195 | 26.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $2,971 | $993.46 | 33.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 86 | $4,316 | $898.77 | 20.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $610.00 | $587.47 | 96.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $560.00 | $417.38 | 74.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 318 | $124,344 | $31,351 | 25.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 252 | $75,852 | $20,050 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $34,937 | $8,716 | 24.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 42 | $24,696 | $6,315 | 25.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 15 | 25 | $20,125 | $4,309 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 26 | $13,972 | $3,485 | 24.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 31 | $6,510 | $1,733 | 26.6% |
About Dr. Gregory Mauldin, MD
Dr. Gregory Mauldin, MD is a Pulmonary Disease healthcare provider based in Snellville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871673749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Mauldin, MD has received a total of $432,873 in payments from pharmaceutical and medical device companies, with $2,886 received in 2024. These payments were reported across 1,306 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($339,385).
As a Medicare-enrolled provider, Mauldin has provided services to 2,473 Medicare beneficiaries, totaling 3,793 services with total Medicare billing of $325,786. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Snellville, GA
- Active Since 10/16/2006
- Last Updated 07/19/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1871673749
Products in Payments
- BEVESPI AEROSPHERE (Drug) $85,018
- TRELEGY ELLIPTA (Drug) $61,427
- FASENRA (Drug) $51,121
- Yupelri (Drug) $48,745
- XARELTO (Drug) $41,489
- DUPIXENT (Biological) $31,773
- SYMBICORT (Drug) $30,382
- UTIBRON (Drug) $28,486
- ANORO (Drug) $14,555
- NUCALA (Biological) $9,505
- LONHALA MAGNAIR (Drug) $5,132
- SPIRIVA RESPIMAT (Drug) $2,673
- TEZSPIRE (Biological) $1,100
- DALIRESP (Drug) $1,039
- FASENRA (Biological) $873.67
- OFEV (Drug) $785.09
- BROVANA (Drug) $509.06
- ANORO ELLIPTA (Drug) $442.37
- Single Use Guide Sheath Kit (Device) $401.58
- STIOLTO RESPIMAT (Drug) $363.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Snellville
Amsel Siore, Md, MD
Pulmonary Disease — Payments: $24,185
Pulmonary Disease $24,185
Douglas Isenstein, Md, MD
Pulmonary Disease — Payments: $2,743
Pulmonary Disease $2,743
Ali Saligheh Araghi, Md, MD
Pulmonary Disease — Payments: $1,421
Pulmonary Disease $1,421
Susan Grey, Md, MD
Pulmonary Disease
Pulmonary Disease